Dr Richard Bergeron (M.D., Ph.D., FRCPC)
Dr. Richard Bergeron is a psychatrist and a researcher in the Departement of Neurosciences at the Ottawa Hospital Research Institute.
He received his medical degree from the Unitversiy of Sherbooke (QC). He further completed a specialty in psychiatry at the University of Ottawa (ON). He received a doctorate at the University of McGill (QC) in neurosciences in 1996 and furthered his research training by completing a postdoctoral fellowship at Havard University (U.S.) from 1997-2002.
As a doctor, he specializes in the treatment of patients with cognitive disorders such as Alzheimer’s disease. He is part of a group of experts that evaluate patients provide them with an innovative treatment adapted for each individueal.
Dr. Bergeron and his team have been conducting clinical research studies for many years and have extensive expertise in this field. Each member of the team has received training and follow the principals of « Good Clinical Practice ». Many have also received extensive training in evaluating the symptoms of Alzheimer’s Disease.
Dr Bergeron also leads a group of graduate students, technicians, and postdoctoral fellows in his reserach laboratory at the Ottawa Hospital Research Institute. His lab focuses on researching the role of glutamate in transmission and synapse. This research is directly related to neurodegenarative disorders, including Alzheimer’s disease.
Dr. Bergeron’s research is possible due to grants received from national and international agencies. He is published in many renowned scientific journals. He is often invited to provide information at conferences within the scientific community, as well as the general public.
« Our best tool in fighting this disease is research.»
Dr Richard Bergeron